The cytoskeleton-associated PDZ-LIM protein, ALP, acts on serum response factor activity to regulate muscle differentiation

Molecular Biology of the Cell

Volumn 18, Issue 5, 2007, Pages 1723-1733

  Pomiès, Pascal ^a   Pashmforoush, Mohammad ^b   Vegezzi, Cristina ^c   Chien, Kenneth R ^b   Auffray, Charles ^a   Beckerle, Mary C ^c  

^a CNRS   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALP PROTEIN; COMPLEMENTARY RNA; JASPAMIDE; LIM PROTEIN; MAL PROTEIN; MEMBRANE PROTEIN; MYOD PROTEIN; MYOGENIN; PDZ PROTEIN; PROTEIN DERIVATIVE; SERUM RESPONSE FACTOR; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL THERAPY; CYTOSKELETON; DYNAMICS; MODULATION; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM;

ACTININ; ACTINS; ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CYTOSKELETON; DNA PRIMERS; GENE EXPRESSION; MICE; MICROFILAMENT PROTEINS; MUSCLE DEVELOPMENT; MYOBLASTS, SKELETAL; MYOD PROTEIN; MYOGENIC REGULATORY FACTOR 5; RNA, ANTISENSE; SERUM RESPONSE FACTOR; TRANSFECTION;

EID: 34248157682     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E06-09-0815     Document Type: Article

References (52)

1. Arber, S., Halder, G., and Caroni, P. (1994). Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell 79, 221-231.
2. Arsenian, S., Weinhold, B., Oelgeschlager, M., Ruther, U., and Nordheim, A. (1998). Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J. 17, 6289-6299.
3. Bubb, M. R., Spector, I., Beyer, B. B., and Fosen, K. M. (2000). Effects of jasplakinolide on the kinetics of actin polymerization. An explanation for certain in vivo observations. J. Biol. Chem. 275, 5163-5170.
4. Carnac, G., Albagli-Curiel, O., Vandromme, M., Pinset, C., Montarras, D., Laudet, V., and Bonnieu, A. (1992). 3,5,3′-Triiodothyronine positively regulates both MyoD1 gene transcription and terminal differentiation in C2 myoblasts. Mol. Endocrinol. 6, 1185-1194.
5. Carnac, G., Primig, M., Kitzmann, M., Chafey, P., Tuil, D., Lamb, N., and Fernandez, A. (1998). RhoA GTPase and serum response factor control selectively the expression of MyoD without affecting Myf5 in mouse myoblasts. Mol. Biol. Cell 9, 1891-1902.
6. Chen, S. L., Dowhan, D. H., Hosking, B. M., and Muscat, G. E. (2000). The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. Genes Dev. 14, 1209-1228.
7. Copeland, J. W., and Treisman, R. (2002). The diaphanous-related formin mDia1 controls serum response factor activity through its effects on actin polymerization. Mol. Biol. Cell 13, 4088-4099.
8. Cossu, G., Kelly, R., Tajbakhsh, S., Di Donna, S., Vivarelli, E., and Buckingham, M. (1996). Activation of different myogenic pathways: myf-5 is induced by the neural tube and MyoD by the dorsal ectoderm in mouse paraxial mesoderm. Development 122, 429-437.
9. Dedieu, S., Mazeres, G., Cottin, P., and Brustis, J. J. (2002). Involvement of myogenic regulator factors during fusion in the cell line C2C12. Int. J. Dev. Biol. 46, 235-241.
10. Delfini, M. C., Hirsinger, E., Pourquie, O., and Duprez, D. (2000). Delta 1-activated notch inhibits muscle differentiation without affecting Myf5 and Pax3 expression in chick limb myogenesis. Development 127, 5213-5224.
11. Dhawan, J., and Helfman, D. M. (2004). Modulation of acto-myosin contractility in skeletal muscle myoblasts uncouples growth arrest from differentiation. J. Cell Sci. 117, 3735-3748.
12. Galbiati, F., Volonte, D., Engelman, J. A., Scherer, P. E., and Lisanti, M. P. (1999). Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J. Biol. Chem. 274, 30315-30321.
13. Gauthier-Rouviere, C., Vandromme, M., Tuil, D., Lautredou, N., Morris, M., Soulez, M., Kahn, A., Fernandez, A., and Lamb, N. (1996). Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts. Mol. Biol. Cell 7, 719-729.
14. Geneste, O., Copeland, J. W., and Treisman, R. (2002). LIM kinase and Diaphanous cooperate to regulate serum response factor and actin dynamics. J. Cell Biol. 157, 831-838.
15. Goodman, A., Goode, B. L., Matsudaira, P., and Fink, G. R. (2003). The Saccharomyces cerevisiae calponin/transgelin homolog Scp1 functions with fimbrin to regulate stability and organization of the actin cytoskeleton. Mol. Biol. Cell 14, 2617-2629.
16. Grosse, R., Copeland, J. W., Newsome, T. P., Way, M., and Treisman, R. (2003). A role for VASP in RhoA-Diaphanous signalling to acrin dynamics and SRF activity. EMBO J. 22, 3050-3061.
17. Guy, P. M., Kenny, D. A., and Gill, G. N. (1999). The PDZ domain of the LIM protein enigma binds to beta-tropomyosin. Mol. Biol. Cell 10, 1973-1984.
18. Hadchouel, J. et al. (2003). Analysis of a key regulatory region upstream of the Myf5 gene reveals multiple phases of myogenesis, orchestrated at each site by a combination of elements dispersed throughout the locus. Development 130, 3415-3426.
19. Hinterberger, T. J., Sassoon, D. A., Rhodes, S. J., and Konieczny, S. F. (1991). Expression of the muscle regulatory factor MRF4 during somite and skeletal myofiber development. Dev. Biol. 147, 144-156.
20. Jo, K., Rutten, B., Bunn, R. C., and Bredt, D. S. (2001). Actihin-associated LIM protein-deficient mice maintain normal development and structure of skeletal muscle. Mol. Cell. Biol. 21, 1682-1687.
21. Johansen, F. E., and Prywes, R. (1995). Serum response factor: transcriptional regulation of genes induced by growth factors and differentiation. Biochim. Biophys. Acta 1242, 1-10.
22. Kotaka, M., Ngai, S. M., Garcia-Barcelo, M., Tsui, S. K., Fung, K. P., Lee, C. Y., and Waye, M. M. (1999). Characterization of the human 36-kDa carboxyl terminal LIM domain protein (hCLIM1). J. Cell. Biochem. 72, 279-285.
23. Kuroda, S., Tokunaga, C., Kiyohara, Y., Higuchi, O., Konishi, H., Mizuno, K., Gill, G. N., and Kikkawa, U. (1996). Protein-protein interaction of zinc finger LIM domains with protein kinase C. J. Biol. Chem. 271, 31029-31032.
24. L'Honore, A., Lamb, N. J., Vandromme, M., Turowski, P., Carnac, G., and Fernandez, A. (2003). MyoD distal regulatory region contains an SRF binding CArG element required for MyoD expression in skeletal myoblasts and during muscle regeneration. Mol. Biol. Cell 14, 2151-2162.
25. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
26. Lowe, D. A., and Alway, S. E. (1999). Stretch-induced myogenin, MyoD, and MRF4 expression and acute hypertrophy in quail slow-tonic muscle are not dependent upon satellite cell proliferation. Cell Tissue Res. 296, 531-539.
27. Ludolph, D. C., and Konieczny, S. F. (1995). Transcription factor families: muscling in on the myogenic program. FASEB J. 9, 1595-1604.
28. Megeney, L. A., Kablar, B., Garrett, K., Anderson, J. E., and Rudnicki, M. A. (1996). MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 10, 1173-1183.
29. Miralles, F., Posern, G., Zaromytidou, A. I., and Treisman, R. (2003). Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113, 329-342.
30. Montanaro, F., Lindenbaum, M., and Carbonetto, S. (1999). alpha-Dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability. J. Cell Biol. 145, 1325-1340.
31. Montarras, D., Aurade, F., Johnson, T., Ilan, J., Gros, F., and Pinset, C. (1996). Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin-like growth factor II and MyoD, operating as early as at the myoblast stage. J. Cell Sci. 109(Pt 3), 551-560.
32. Montarras, D., Chelly, J., Bober, E., Arnold, H., Ott, M. O., Gros, F., and Pinset, C. (1991). Developmental patterns in the expression of Myf5, MyoD, myogenin, and MRF4 during myogenesis. New Biol. 3, 592-600.
33. Olson, E. N. (1992). Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol. 154, 261-272.
34. Ornatsky, O. I., Andreucci, J. J., and McDermott, J. C. (1997). A dominant-negative form of transcription factor MEF2 inhibits myogenesis. J. Biol. Chem. 272, 33271-33278.
35. Parker, M. H., Seale, P., and Rudnicki, M. A. (2003). Looking back to the embryo: denning transcriptional networks in adult myogenesis. Nat. Rev. Genet. 4, 497-507.
36. Pashmforoush, M., Pomies, P., Peterson, K. L., Kubalak, S., Ross, J., Jr., Hefti, A., Aebi, U., Beckerle, M. C., and Chien, K. R. (2001). Adult mice deficient in actinin-associated LIM-domain protein reveal a developmental pathway for right ventricular cardiomyopathy. Nat. Med. 7, 591-597.
37. Pomies, P., Macalma, T., and Beckerle, M. C. (1999). Purification and characterization of an alpha-actinin-binding PDZ-LIM protein that is up-regulated during muscle differentiation. J. Biol. Chem. 274, 29242-29250.
38. Rudnicki, M. A., Braun, T., Hinuma, S., and Jaenisch, R. (1992). Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71, 383-390.
39. Rudnicki, M. A., and Jaenisch, R. (1995). The MyoD family of transcription factors and skeletal myogenesis. Bioessays 17, 203-209.
40. Shin, S. Y. et al. (2006). Suppression of Egr-1 transcription through targeting of the serum response factor by oncogenic H-Ras. EMBO J. 25, 1093-1103.
41. Sotiropoulos, A., Gineitis, D., Copeland, J., and Treisman, R. (1999). Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98, 159-169.
42. Tajbakhsh, S., Rocancourt, D., and Buckingham, M. (1996). Muscle progenitor cells failing to respond to positional cues adopt non-myogenic fates in myf-5 null mice. Nature 384, 266-270.
43. Treisman, R. (1994). Ternary complex factors: growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 4, 96-101.
44. Treisman, R. (1995). Journey to the surface of the cell: Fos regulation and the SRE. EMBO J. 14, 4905-4913.
45. Vallenius, T., Scharm, B., Vesikansa, A., Luukko, K., Schafer, R., and Makela, T. P. (2004). The PDZ-LIM protein RIL modulates actin stress fiber turnover and enhances the association of alpha-actinin with F-actin. Exp. Cell Res. 293, 117-128.
46. Venuti, J. M., Morris, J. H., Vivian, J. L., Olson, E. N., and Klein, W. H. (1995). Myogenin is required for late but not early aspects of myogenesis during mouse development. J. Cell Biol. 128, 563-576.
47. Wang, D. Z., and Olson, E. N. (2004). Control of smooth muscle development by the myocardin family of transcriptional reactivators. Curr. Opin. Genet. Dev. 14, 558-566.
48. Wang, Y., Krushel, L. A., and Edelman, G. M. (1996). Targeted DNA recombination in vivo using an adenovirus carrying the ere recombinase gene. Proc. Natl. Acad. Sci. USA 93, 3932-3936.
49. Wei, L., Zhou, W., Croissant, J. D., Johansen, F. E., Prywes, R., Balasubramanyam, A., and Schwartz, R. J. (1998). RhoA signaling via serum response factor plays an obligatory role in myogenic differentiation. J. Biol. Chem. 273, 30287-30294.
50. Weintraub, H. (1993). The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75, 1241-1244.
51. Xia, H., Winokur, S. T., Kuo, W. L., Altherr, M. R., and Bredt, D. S. (1997). Actinin-associated LIM protein: identification of a domain interaction between PDZ and spectrin-like repeat motifs. J. Cell Biol. 139, 507-515.
52. Zhou, Q., Ruiz-Lozano, P., Martone, M. E., and Chen, J. (1999). Cypher, a striated muscle-restricted PDZ and LIM domain-containing protein, binds to alpha-actinin-2 and protein kinase C. J. Biol. Chem. 274, 19807-19813.